Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for Advanced Cirrhosis After TIPS
NCT03005444Unknown
- Sponsor
- Air Force Medical University
- Start
- Jun 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rivaroxaban in Liver cirrhosis (LC) (2 arms), sponsored by Air Force Medical University. Primary endpoint: Transplant-free survival at 2 years. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03005444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005444.